tiprankstipranks
Trending News
More News >
Theralase Technologies (TSE:TLT)
:TLT
Canadian Market

Theralase Technologies (TLT) Income Statement

Compare
92 Followers

Theralase Technologies Income Statement

Last quarter (Q3 2025), Theralase Technologies's total revenue was C$279.64K, a decrease of -19.32% from the same quarter last year. In Q3, Theralase Technologies's net income was C$-1.01M. See Theralase Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 1.03MC$ 1.07MC$ 1.14MC$ 780.64KC$ 929.12K
Gross Profit
C$ 554.03KC$ 562.13KC$ 628.17KC$ 309.94KC$ 269.68K
Operating Expenses
C$ 4.84MC$ 5.15MC$ 5.86MC$ 4.85MC$ 5.97M
Depreciation and Amortization
C$ 272.09KC$ 286.12KC$ 313.23KC$ 276.15KC$ 272.28K
EBITDA
C$ -3.96MC$ -4.25MC$ -4.90MC$ -4.31MC$ -5.56M
Operating Income
C$ -4.29MC$ -4.59MC$ -5.20MC$ -4.52MC$ -5.59M
Other Income/Expenses
C$ 32.23KC$ 23.39KC$ -3.76KC$ 130.48KC$ 124.03K
Pretax Income
C$ -4.26MC$ -4.57MC$ -5.24MC$ -4.41MC$ -5.60M
Net Income
C$ -4.26MC$ -4.57MC$ -5.25MC$ -4.42MC$ -5.61M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.02C$ -0.03C$ -0.02C$ -0.03
Diluted EPS
C$ -0.02C$ -0.02C$ -0.03C$ -0.02C$ -0.03
Weighted Average Shares Outstanding
240.07M 219.97M 207.92M 204.28M 204.28M
Weighted Average Shares Outstanding (Diluted)
240.07M 219.97M 207.92M 204.28M 204.28M
Currency in CAD

Theralase Technologies Earnings and Revenue History